145 related articles for article (PubMed ID: 30799937)
1. CHFR promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a HDAC1-dependent manner.
Yang S; He F; Dai M; Pan J; Wang J; Ye B
Onco Targets Ther; 2019; 12():1075-1084. PubMed ID: 30799937
[TBL] [Abstract][Full Text] [Related]
2. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis.
He F; Ye B; Wu X; Pan J; Wang J; Wang X
BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798
[TBL] [Abstract][Full Text] [Related]
3. CHFR‑mediated epithelial‑to‑mesenchymal transition promotes metastasis in human breast cancer cells.
Jiang G; Fang H; Shang X; Chen X; Cao F
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880594
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers.
Zhang D; Xu XL; Li F; Sun HC; Cui YQ; Liu S; Xu PY
Oncol Lett; 2017 Dec; 14(6):8042-8050. PubMed ID: 29344247
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.
Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T
Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of
Ding Y; Lian HF; Du Y
Oncotarget; 2018 Feb; 9(11):10083-10090. PubMed ID: 29515792
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of negative regulator of ubiquitin-like proteins 1 (NUB1) inhibits proliferation and invasion of gastric cancer cells through upregulation of p27Kip1 and inhibition of epithelial-mesenchymal transition.
Zhang D; Wu P; Zhang Z; An W; Zhang C; Pan S; Tan Y; Xu H
Pathol Res Pract; 2020 Aug; 216(8):153002. PubMed ID: 32703484
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
[TBL] [Abstract][Full Text] [Related]
9. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.
Kashima L; Idogawa M; Mita H; Shitashige M; Yamada T; Ogi K; Suzuki H; Toyota M; Ariga H; Sasaki Y; Tokino T
J Biol Chem; 2012 Apr; 287(16):12975-84. PubMed ID: 22337872
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
[TBL] [Abstract][Full Text] [Related]
12. Chfr is linked to tumour metastasis through the downregulation of HDAC1.
Oh YM; Kwon YE; Kim JM; Bae SJ; Lee BK; Yoo SJ; Chung CH; Deshaies RJ; Seol JH
Nat Cell Biol; 2009 Mar; 11(3):295-302. PubMed ID: 19182791
[TBL] [Abstract][Full Text] [Related]
13. PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.
Cai XP; Chen LD; Song HB; Zhang CX; Yuan ZW; Xiang ZX
Am J Transl Res; 2016; 8(10):4172-4183. PubMed ID: 27830001
[TBL] [Abstract][Full Text] [Related]
14. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.
Kashima L; Toyota M; Mita H; Suzuki H; Idogawa M; Ogi K; Sasaki Y; Tokino T
Oncogene; 2009 Jul; 28(29):2643-53. PubMed ID: 19448676
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial-mesenchymal transition.
Yin H; Huang X; Tao M; Hu Q; Qiu J; Chen W; Wu J; Xie Y
Cancer Gene Ther; 2017 Apr; 24(4):180-188. PubMed ID: 28186089
[TBL] [Abstract][Full Text] [Related]
16. WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition.
Ye D; Ma W; Xu J; Zhu G; Liu D; Liu C; Ding Y; Zhang Q
Oncol Lett; 2018 Oct; 16(4):4970-4976. PubMed ID: 30250562
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer.
Suzuki Y; Miyagi Y; Yukawa N; Rino Y; Masuda M
Oncol Lett; 2014 Jan; 7(1):69-73. PubMed ID: 24348823
[TBL] [Abstract][Full Text] [Related]
18. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Sato S; Miyazaki K
J Gastroenterol; 2006 Feb; 41(2):133-9. PubMed ID: 16568372
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
20. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
Fukuda T; Kondo Y; Nakagama H
PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
